Skip to content

Antlia Bioscience, Inc. vs Structure Therapeutics

Antlia Bioscience, Inc. logo

Antlia Bioscience, Inc.

Turning promising peptides into groundbreaking therapeutics for chronic diseases

4 employees · est. 2021 · Encinitas, United States

VS
Structure Therapeutics logo

Structure Therapeutics

Developing accessible oral small molecule therapies for the treatment of chronic diseases including obesity

219 employees · est. 2017 · South San Francisco, United...

Structure Therapeutics is the older company (2021 vs 2017); Structure Therapeutics is the larger of the two.

Side-by-Side Comparison

Antlia Bioscience, Inc. Structure Therapeutics
Founded
2021 2017 older
Headquarters
Encinitas, United States South San Francisco, United States
Employees
4 219 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Pharmaceutical
Funding Stage
Not tracked yet IPO
Total Funding
Not tracked yet $1.79B
Funding Rounds
Not tracked yet 8
Taxonomy
TherapeuticsPeptidesChronic DiseasesPASylation®PharmacokineticsCardiovascular Diseases +6 Life-changing MedicinesComputational ChemistryStructure-based TechnologyClinical-stage PipelineChronic DiseasesBiologic And Peptide Drugs +9
Website
antliabio.com structuretx.com
Antlia Bioscience, Inc. logo

About Antlia Bioscience, Inc.

Antlia Bioscience, Inc. is a biotechnology startup founded in 2020 with a mission to develop revolutionary therapeutics for chronic diseases. Utilizing its proprietary chemistry platform, PASylation®, the company is focused on engineering long-acting peptides with refined pharmacologic and pharmacok...

Structure Therapeutics logo

About Structure Therapeutics

Structure Therapeutics is a biotechnology startup founded in 2016, headquartered in the United States. The company is focused on creating innovative, life-changing medicines for patients using advanced computational and structure-based technology. Its platform integrates computational chemistry and...

Also comparing in this category

Comparing more than these two?

Get Antlia Bioscience, Inc., Structure Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Antlia Bioscience, Inc. compare?

A PDF of Antlia Bioscience, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Antlia Bioscience, Inc. was founded in 2021, based in Encinitas, United States, with 4 employees. Antlia Bioscience, Inc. is a biotechnology startup founded in 2020 with a mission to develop revolutionary therapeutics for chronic diseases. Utilizing its proprietary chemistry platform, PASylation®,. Structure Therapeutics was founded in 2017, based in South San Francisco, United States, with 219 employees. Structure Therapeutics is a biotechnology startup founded in 2016, headquartered in the United States. The company is focused on creating innovative, life-changing medicines for patients using advance.
Antlia Bioscience, Inc. has raised no disclosed funding and Structure Therapeutics $1.79B. Latest stage: Structure Therapeutics IPO.
Both work in Biotechnology and Health Care and list chronic diseases, cardiovascular diseases and metabolic diseases among their focus areas.

Compare Antlia Bioscience, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Antlia Bioscience, Inc. on 12 Sep 2024, and Structure Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout